Life Sciences Regulatory Compliance Consulting
Boutique advisory firm delivering FDA pathway guidance, San Francisco-specific tax and permitting navigation, quality system implementation, and scaling support exclusively for mid-stage biotech and medtech companies.
San Francisco biotech companies in the Mission Bay cluster face persistent bottlenecks from complex FDA pathways and local tax and permitting rules that slow scaling and increase risk. Our Life Sciences Regulatory Compliance Consulting firm delivers specialized advisory on FDA guidance, quality systems, and San Francisco-specific compliance exclusively for mid-stage biotech and medtech firms. We project Year 1 revenue of $450,000 to $850,000 in a $2.4-3.6 billion SAM with break-even in 6 months at 52% margins. The time is now in San Francisco as the dense concentration of high-value clients and acute unmet demand for local expertise enable rapid client acquisition and robust pricing power.
- Startup
- $215K
- Monthly profit
- $64K
- Margin
- 57%
- Breakeven
- —
